Dr.med. ID: 5810778

Dominik Sebastian Nörz

graph of relations

Publications

  1. 2014
  2. Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors

    Ewald, F., Nörz, D., Grottke, A., Hofmann, B. T., Nashan, B. & Jücker, M., 2014, In: INVEST NEW DRUG. 32, 6, p. 1144-54 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2013
  4. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma

    Ewald, F., Grabinski, N., Grottke, A., Windhorst, S., Nörz, D., Carstensen, L., Staufer, K., Hofmann, B. T., Diehl, F., David, K., Schumacher, U., Nashan, B. & Jücker, M., 01.11.2013, In: INT J CANCER. 133, 9, p. 2065-76 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 Next